Natreon Ripe with Clinical Research

November 21, 2013

The company plans to publish 10 "gold standard" trials on its ingredients in the coming year.

Natreon (New Brunswick, NJ) has plans to publish more than 10 “gold standard” human trials on its ingredients in the upcoming year. When it’s all said and done, the published studies will be the culmination of more than $1 million invested in clinical research to keep up with growing demands from dietary supplement manufacturers.

The trials focus on Natreon’s branded ingredients, which are Sensoril ashwagandha, Capros amla fruit, Crominex3+ chromium complex, and PrimaVia shilajit-a blackish brown powder from high-mountain rocks. Findings reportedly span a wide range of health conditions, including stress relief, blood sugar control, heart health, energy, and sports performance. While the first study will likely publish before the end of this year, the others won’t be released until 2014. But the wait should be worth it. Natreon says it has shared findings with some nutritional product manufacturers and is planning to announce an exclusive supply agreement with a dietary supplement manufacturer before the end of this year.